Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

NTLANTLA
17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in INTELLIA THERAPEUTICS INC

Yes. Goldman Sachs holds 2,264,471 shares of NTLA (Intellia Therapeutics), worth $38.3M, as of its Q2 2026 13F filing. It increased the position by 636,230 shares (+39.1%) from Q1 2026. Goldman Sachs has held NTLA in every 13F on record since Q2 2022, 17 quarterly filings.

Current Value

$38.3M

Current Shares

2.3M

Total Value Change

-$5.6M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+39.1%
$38.3M0.0%$16.92
38
2026-Q1
Increased
1.6M
+11.9%
$20.9M0.0%$12.82
32
2025-Q4
Decreased
1.5M
-66.0%
$13.1M0.0%$8.99
0
2025-Q3
Increased
4.3M
+109.0%
$73.9M0.0%$17.27
48
2025-Q2
Decreased
2M
-15.2%
$19.2M0.0%$9.38
0
2025-Q1
Increased
2.4M
+18.6%
$17.2M0.0%$7.11
33
2024-Q4
Increased
2M
+96.7%
$23.7M0.0%$11.66
46
2024-Q3
Decreased
1M
-18.3%
$21.3M0.0%$20.55
0
2024-Q2
Increased
1.3M
+18.7%
$28.3M0.0%$22.38
34
2024-Q1
Increased
1.1M
+29.5%
$29.4M0.0%$27.51
36
2023-Q4
Increased
824,527
+3.5%
$25.1M0.0%$30.49
30
2023-Q3
Decreased
796,263
-20.7%
$25.2M0.0%$31.62
0
2023-Q2
Increased
1M
+16.8%
$40.9M0.0%$40.78
34
2023-Q1
Increased
859,482
+37.1%
$32M0.0%$37.27
38
2022-Q4
Decreased
627,094
-36.1%
$21.9M0.0%$34.89
0
2022-Q3
Increased
981,755
+15.8%
$54.9M0.0%$55.96
34
2022-Q2
First report
848,183
-
$43.9M0.0%$51.76
0

Other major holders of NTLA: ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used